Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.
Takahashi H, Kessoku T, Kawanaka M, Nonaka M, Hyogo H, Fujii H, Nakajima T, Imajo K, Tanaka K, Kubotsu Y, Isoda H, Oeda S, Kurai O, Yoneda M, Ono M, Kitajima Y, Tajiri R, Takamori A, Kawaguchi A, Aishima S, Kage M, Nakajima A, Eguchi Y, Anzai K.
Takahashi H, et al. Among authors: tajiri r.
Hepatol Commun. 2022 Jan;6(1):120-132. doi: 10.1002/hep4.1696. Epub 2021 Jun 17.
Hepatol Commun. 2022.
PMID: 34558835
Free PMC article.
Clinical Trial.